Skip to main content

Christopher M. Smith

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christopher M. Smith

Christopher M. Smith is recorded as Board Member at Pacific Biosciences Of California, Inc. (PACB). Earlier roles on record: Board Member at QuidelOrtho Corp (QDEL) until August 31, 2023. Pacific Biosciences Of California, Inc. reported in an 8-K filed July 9, 2026 that Christopher M. Smith resigned as member of the board of directors, effective July 8, 2026. Pacific Biosciences Of California, Inc. reported in an 8-K filed June 4, 2026 that Christopher M. Smith was appointed Class III Director, effective June 3, 2026. Pacific Biosciences Of California, Inc. reported in an 8-K filed June 6, 2025 that Christopher M. Smith was appointed Class III Director, effective June 4, 2025. Equibles holds 5 filed executive changes naming Christopher M. Smith; each is listed under recent activity with its source filing.

“On July 8, 2026, Christopher M. Smith, a member of the board of directors (the "Board") of Pacific Biosciences of California, Inc. (the "Company"), notified the Company of his resignation from the Board, effective immediately.”
Pacific Biosciences Of California, Inc. Form 8-K, filed July 9, 2026 · Read the filing
“Each director nominee was duly elected to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal.”
Pacific Biosciences Of California, Inc. Form 8-K, filed June 4, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Pacific Biosciences Of California, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.